Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-06-30
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Schizophrenia is a major mental disorder that is strongly associated with cognitive deficits. These often appear before the onset of psychotic symptoms and persist throughout effective treatment of positive and negative symptoms. Like other disorders of psychosis, schizophrenia features general deficits in auditory memory and sensory processing. Recently, Sawada et al. (2014) and Wen et al. (2014) studied music abilities in Japanese and Chinese schizophrenic populations. They both used a standardized assessment for amusia called Montreal Battery of Evaluation of Amusia (MBEA) and found marked impairments in perception of scale, contour, interval, rhythm, meter and memory. Both studies showed that deficits in music perception were associated with cognitive deficits and negative symptoms. In regards to positive symptoms, Wen et al., but not Sawada et al., found a significant association.
The present clinical study will assess musical abilities using the MBEA in a Canadian population with and without refractory psychosis. It will explore associations between musical deficits, positive and negative psychiatric symptomology and cognition. The patient population will have a diagnosis of schizophrenia, schizoaffective disorder, affective disorder with psychosis or non substance-related psychosis who were referred to the British Columbia Psychosis Program (BCPP) due to inadequate or no response to at least two trials of antipsychotics. A focus on refractory psychosis may provide greater insights because these patients have relatively more pronounced psychiatric symptoms and cognitive deficits. It will also be valuable to administer the MBEA assessment on a Canadian population, because the test was originally intended for Western populations and its musical phrases were designed with Western tonalities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Music to Reduce Use of Smoking in Patients With Schizophrenia
NCT03190161
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions
NCT00155519
Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia
NCT07055204
Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments
NCT06471179
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
NCT06886945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The perception of music requires coordinated neural activities in distributed multi-functional centers across both hemispheres. The association between musical abilities and other general cognitive functions have been studied in several populations with inconsistent results.
Schizophrenia is a major mental disorder that is strongly associated with cognitive deficits. These often appear before the onset of psychotic symptoms and persist throughout effective treatment of positive and negative symptoms. Like other disorders of psychosis, schizophrenia features general deficits in auditory memory and sensory processing. Recently, Sawada et al. (2014) and Wen et al. (2014) studied music abilities in Japanese and Chinese schizophrenic populations. They both used a standardized assessment for amusia called Montreal Battery of Evaluation of Amusia (MBEA) and found marked impairments in perception of scale, contour, interval, rhythm, meter and memory. Both studies showed that deficits in music perception were associated with cognitive deficits and negative symptoms. In regards to positive symptoms, Wen et al., but not Sawada et al., found a significant association.
The present clinical study will assess musical abilities using the MBEA in a Canadian population with and without refractory psychosis. It will explore associations between musical deficits, positive and negative psychiatric symptomology and cognition. The patient population will have a diagnosis of schizophrenia, schizoaffective disorder, affective disorder with psychosis or non substance-related psychosis who were referred to the British Columbia Psychosis Program (BCPP) due to inadequate or no response to at least two trials of antipsychotics. A focus on refractory psychosis may provide greater insights because these patients have relatively more pronounced psychiatric symptoms and cognitive deficits. It will also be valuable to administer the MBEA assessment on a Canadian population, because the test was originally intended for Western populations and its musical phrases were designed with Western tonalities.
2. RESEARCH OUTLINE This is a cross-sectional, observational study. Participating patients with refractory psychosis and healthy (age- and gender- matched) controls will undergo the Montreal Battery of Evaluation of Amusia assessment and assessments of cognition and symptoms.
The purpose of the study is to describe music perceptive ability in patients with refractory psychosis using the Montreal Battery of Evaluation of Amusia, a standardized and continuous measure of musical ability. The criterion for amusia is a score of 2 standard deviations below the mean of normal participants.
4\) OBJECTIVES
Primary:
The primary objective is to compare music perceptive ability in patients with clinically identified refractory psychosis with healthy subjects.
Secondary:
The secondary objectives are to compare the prevalence of amusia in a population of patients with refractory psychosis versus a population of healthy controls, and to compare psychiatric symptoms and cognition in patients with amusia versus patients without amusia. We will also determine if an association exists between music perceptive ability and:
* General and specific aspects of symptom severity, as assessed by standardized symptom rating scales and neurological status examination.
* General and specific aspects of cognition, as assessed by cognitive tests.
* Demographic variables such as sex, age, musical training and education. In addition, we will investigate potential pathways between symptomologies of psychosis, cognitive deficits and musical disability (if found) by using exploratory mediation analysis.
5\) RESEARCH METHOD We will recruit 100 participants, who will undergo the Montreal Battery of Evaluation of Amusia test and cognitive tests. Of these, 50 will be age- and gender- matched participants not diagnosed with a psychosis disorder who will serve as controls. The remaining 50 participants will be recruited from BCPP at UBC Hospital for in-patients diagnosed with refractory psychosis. For patients, participation will also involve assessments of their mental health (psychiatric symptoms).
6\) STATISTICAL ANALYSIS Inferential analyses will be used to assess differences in musical ability between patients and controls. It will also be used to evaluate differences in psychiatric symptoms and cognition between patients with amusia and those without amusia. Linear regression analyses will be done to relate psychiatric symptoms and cognition to musical ability. Mediation analyses will be performed to determine a causal model between symptoms, cognition and musical ability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls
Participants without a psychosis disorder diagnosis.
No interventions assigned to this group
Patients
Participants with a psychosis disorder diagnosis- recruited from the BC Psychosis Program.
Admission to BCPP
There is no intervention associated with this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Admission to BCPP
There is no intervention associated with this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluency in English (patients and controls)
* Able to give consent
Exclusion Criteria
• Presence of hearing deficits
For controls only, history of:
* Diagnosis of psychosis disorder
* Antipsychotic medications
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alasdair Barr, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC psychosis ward at UBC Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H14-02891
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.